Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.
You're using version {0} of the web browser {1}. This means that the content or functionality of our website may be limited or unavailable. We recommend that you upgrade your browser to optimise your experience of our website.
POOR ANTIBODY RESPONSE TO VACCINATION IN HIV-1 INFECTED CHILDREN CAN BE IMPROVED THROUGH A NOVEL ADJUVANT
| Reference number | 2013-00078 |
| Coordinator | Karolinska institutet - Institutionen för mikrobiologi, tumör- och cellbiologi |
| Funding from Vinnova | SEK 99 666 |
| Project duration | January 2013 - March 2013 |
| Status | Completed |
Last updated 25 November 2019
Reference number 2013-00078
